跳至主要内容
临床试验/DRKS00010288
DRKS00010288招募中不适用

Registry for BCR-ABL negative myeloproliferative neoplasms - Freiburg MPN Register

niversitätsklinikum Freiburg Innere Medizin I - Hämatologie und Onkologie0 个研究点目标入组 1,000 人开始时间: 2016年4月18日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 120 Years(—)
性别
All

入选标准

  • Age =18 years
  • - Patients with BCR-ABL negative MPN of the following entitities: primary myelofibrosis (PMF), polycythemia vera (PV), essential thrombocythemia (ET), post-PV or ET myelofibrosis (PPVMF/PETMF), systemic mastozytosis (SM), unclassifiable myeloproliferative neoplasm (MPN, U) or acute myeloid leukemia (AML) after MPN
  • - Signed informed consent

排除标准

  • 未提供

研究者

发起方
niversitätsklinikum Freiburg Innere Medizin I - Hämatologie und Onkologie

相似试验

招募中
不适用
German MPN-Registry for BCR-ABL1-Negative Myeloid Neoplasms of the German Study Group MPN (GSG-MPN)Myeloproliferative neoplasms: Polycythemia vera (PV)Primary myelofibrosis (PMF)Essential thrombocythemia (ET)MPN unclassifiable (MPNu)Myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB, or FGFR1MDS/MPND45D47.3D47.4D47.1D47.5Polycythaemia veraEssential (haemorrhagic) thrombocythaemiaOsteomyelofibrosisChronic myeloproliferative diseaseChronic eosinophilic leukaemia [hypereosinophilic syndrome]Chronic eosinophilic leukemia
DRKS00006035Klinik für Hämatologie, Onkologie, Hämostaseologie und SZT, Uniklinik RWTH Aachen999,999
招募中
不适用
German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm)BCR-ABL1-Negative Myeloid Neoplasms
NCT03125707University of Ulm2,172
尚未招募
不适用
A New Blood Score for Myelofibrosis StagingMyeloproliferative Neoplasm
NCT06177366Assistance Publique - Hôpitaux de Paris120
招募中
不适用
Inherited Bone Marrow Failure Syndrome RegistryInherited bone marrow failure syndrome
JPRN-UMIN000042088Hirosaki University Graduate School of Medicine9,999
暂停
不适用
Myeloproliferative Neoplasms Registry (ALLG MPN01)Polycythaemia vera (PV)Essential thrombocythaemia (ET)Primary myelofibrosis (PMF)Myeloproliferative neoplasm – unclassifiable (MPN-NOS)Chronic eosinophilic leukaemia (CEL)Hypereosinophilic syndrome (HES)Refractory anaemia with ring sideroblasts associated with marked thrombocytosis (RARS-t)Cancer - Other cancer types
ACTRN12613000138785Australasian Leukaemia and Lymphoma Group (ALLG)300